Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane and Goserelin in Premenopausal Metastatic Breast Cancer
NCT00010010Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2000
- Primary completion
- May 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exemestane in breast cancer, sponsored by NYU Langone Health. Started Jun 2000; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00010010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010010.